Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Lapatinib and Trastuzumab With or Without Endocrine Therapy in Locally Advanced HER2 Overexpressing Breast Cancer Patients

NCT00548184 is registered in ClinicalTrials.gov with Baylor Breast Care Center as lead sponsor.

NCT NCT00548184
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00548184 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Lapatinib and Trastuzumab With or Without Endocrine Therapy in Locally Advanced HER2 Overexpressing Breast Cancer Patients
Lead sponsor
Baylor Breast Care Center
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2008
Completion date
January 31, 2014
Enrollment
65 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer